Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

BioDrain Streamway® System Receives Positive Evaluations on Two Additional Units

June 27, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, June 27, 2011 /- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, today announced that it has placed two additional units and that new evaluations are underway at surgical facilities...

Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®

June 27, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 27, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that its founder and CEO, Jay Yadav, M.D. , has been honored with...

Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

SEATTLE, June 27, 2011 /- Omeros Corporation (NASDAQ: OMER ) today reported that it has identified compounds that interact with orphan G protein-coupled receptors (GPCRs) P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated with acute lymphoblastic leukemia (ALL), an aggressive cancer...

Advertisement

Cellular Dynamics International Unlocks the Potential of Banked Blood Samples

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 27, 2011 /- Cellular Dynamics International (CDI) today announced the online publication of an article in the journal Blood demonstrating for the first time a methodology for researchers to access the biology stored in repositories of banked blood samples through the...

ERA-EDTA Congress 2011: Late Breaking Clinical Trials II

June 25, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

PRAGUE, June 25, 2011 /-   The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients. Whether it also has a favourable effect on renal disease progression was another of the...

Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe

June 24, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn. and INDIANAPOLIS, June 24, 2011 /- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY ) today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed...

Ceramic Replaces Titanium With Machining Assistance

June 22, 2011 9:55 am | by Klaus A. Burckhardt, PE | Articles | Comments

Coated titanium was to be replaced as the material for the stator housing in a right ventrical assist device. Zirconia ceramic was the material selected and expert machining met the needs for very tight tolerances to fabricate the component.

CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary

June 22, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 22, 2011 /- CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer of its magnetic beads business unit, which develops ultra sensitive magnetic beads for use in diagnostic devices, into its Canadian subsidiary, Luxspheres Inc. The beads business unit,...

Advertisement

Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation

June 22, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 22, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company’s Generx...

Alzheimer's Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimer's Disease

June 22, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK , June 22, 2011 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation. (Logo:...

iHealth Lab's Blood Pressure Self-Monitoring System Gets Nationwide Distribution

June 22, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 22, 2011 /- (Digital Experience!) -- iHealth Lab Inc., the pioneering designer and manufacturer of digital personal healthcare products including the iHealth BP3 Blood Pressure Monitoring System for iPhone, iPod touch and iPad, today announced that multiple national retail...

Chinmax Disclaims Liability Following China SFDA's Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission o...

June 21, 2011 7:44 am | by Bio-Medicine.Org | News | Comments

BEIJING, June 21, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc. , a leading cardiac biomarker distributor in China, announced today that it disclaims all liability in connection with an official letter it received from the China State Food and Drug Administration (SFDA) on June...

BYDUREONâ„¢ RECEIVES MARKETING AUTHORIZATION IN EUROPE

June 21, 2011 3:39 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, SAN DIEGO and WALTHAM, Mass., June 21, 2011 /- Eli Lilly and Company (NYSE: LLY ), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Alkermes, Inc. (Nasdaq: ALKS ), announced today that the European Commission has granted marketing authorization to...

Advertisement

FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System

June 20, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States. (Logo:  ...

BioDrain Medical, Inc. Reports Results of Annual Meeting

June 20, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, June 20, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, today announced the results of the Company's Annual Shareholder Meeting, held on June 14, 2011. Shareholders approved...

Reportlinker Adds Endovascular Surgical Interventions: Technology Market Penetration and Roadmapping

June 20, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Endovascular Surgical Interventions: Technology Market Penetration and Roadmapping...

Franciscan St. Francis Heart Center Surgeon Pioneers Use of Heart Valve Repair Ring

June 17, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 17, 2011 /- The St. Francis Heart Center  today (June 17, 2011) announced that it has performed the first post-FDA approval surgery in the United States using a new device for treating tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the...

Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference

June 17, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BEDMINSTER, N.J., June 17, 2011 /- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief Executive Officer, will present at the 2011 Wells Fargo Securities Healthcare Conference at the...

ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference

June 16, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., June 16, 2011 /- ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today it will be participating in the OnemedForumNY 2011 Conference on Thursday, June 23. The presentation by...

ViaCyte Names Michael Scott Vice President, Device Research & Development

June 15, 2011 12:33 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 15, 2011 /- ViaCyte, Inc. today announced the appointment of Michael J. Scott, Ph.D. as Vice President, Device Research and Development, reporting to John West, President and Chief Executive Officer.  In this capacity, Dr. Scott will oversee all device development and...

American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates

June 15, 2011 12:32 pm | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., June 15, 2011 /- American Regent is conducting a voluntary nationwide recall to the user and consumer level of the following product: Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial, Lot # 0362, Expiration Date: May 2012, NDC # 0517-2930-25 PL...

Cordis Announces Discontinuation of NEVOâ„¢ Sirolimus-Eluting Coronary Stent

June 15, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., June 15, 2011 /- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced it will no longer pursue the development of the NEVO™ Sirolimus-Eluting Coronary Stent in order to focus on other...

B. Braun Medical Inc. Named Best Company to Work For

June 15, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., June 15, 2011 /- B. Braun Medical Inc. (B. Braun) is part of one of the fastest growing medical technology corporations in the world -- it's also one of the Best Companies to Work For , according to Medical Device and Diagnostic Industry (MD+DI) magazine. One of just 10...

Masimo Announces Rainbow Agreement with Philips

June 15, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 15, 2011 /- Masimo (NASDAQ: MASI ) today announced that it has reached a long-term non-exclusive agreement under which Philips will integrate Masimo rainbow SET® technology into Philips' products.  Masimo expects to begin diligent co-development projects...

Dr. F. John Mills Joins Intelsius' Board of Directors as Non-Executive Chair

June 15, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

YORK, England, June 15, 2011 /- Intelsius, a global manufacturer and distributor of environmentally safe, temperature-controlled and regulatory-compliant packaging solutions, announced today that it has appointed Dr. F. John Mills, M.D., Ph.D., to the company's board of directors as...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading